01—Abstract
Summary
Summary of the 8-K filed October 3, 2025. Cited figures are marked; the original filing is the authoritative source.
Incyte Corporation (INCY) filed a Form 8-K on October 3, 2025 under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
The filing reports that on September 30, 2025, the Board of Directors appointed Thomas Tray, the Company's Vice President, Finance and Chief Accounting Officer (principal accounting officer), to the additional position of principal financial officer, effective as of September 16, 2025. Mr. Tray, age 48, joined Incyte in June 2005 as Manager, External Reporting, and has since held roles of increasing responsibility, most recently as Vice President and Controller before his current role. He holds a B.S. in Accounting from Mount Saint Mary's University and an Executive MBA in Pharmaceutical Marketing from Saint Joseph's University.
The filing states that there are no arrangements or understandings between Mr. Tray and any other persons pursuant to which he was appointed as principal financial officer, that he has no family relationships with the Company's directors or executive officers, and that he has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K. The filing contains no compensation terms for the appointment.
02—Key points
Key Highlights
- Thomas Tray, Vice President, Finance and Chief Accounting Officer, was appointed principal financial officer in addition to his existing principal accounting officer role.
- The appointment was approved by the Board of Directors on September 30, 2025, and is effective as of September 16, 2025.
- Mr. Tray, age 48, joined Incyte in June 2005 and most recently served as Vice President and Controller.
- Mr. Tray holds a B.S. in Accounting from Mount Saint Mary's University and an Executive MBA in Pharmaceutical Marketing from Saint Joseph's University.
- The filing states there are no arrangements or understandings tied to the appointment and no family relationships with directors or executive officers.
- The filing states Mr. Tray has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.
- The filing does not describe any change in Mr. Tray's compensation in connection with the appointment.
03—Questions
Frequently Asked Questions
Who was appointed principal financial officer of Incyte?
Thomas Tray, the Company's Vice President, Finance and Chief Accounting Officer, was appointed to the additional position of principal financial officer. He continues to serve as principal accounting officer.
When did the appointment take effect?
The appointment is effective as of September 16, 2025. The Board of Directors made the appointment on September 30, 2025, and the filing was dated October 3, 2025.
What is Mr. Tray's professional background?
Mr. Tray joined Incyte in June 2005 as Manager, External Reporting, and held roles of increasing responsibility, most recently as Vice President and Controller before his current role. He received a B.S. in Accounting from Mount Saint Mary's University and an Executive MBA in Pharmaceutical Marketing from Saint Joseph's University.
Are there any related-party or family relationships tied to the appointment?
The filing states there are no arrangements or understandings with any other persons pursuant to which Mr. Tray was appointed, he has no family relationships with the Company's directors or executive officers, and he has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.
Does the filing disclose compensation changes for Mr. Tray?
No. The filing does not describe any change to Mr. Tray's compensation or other compensatory arrangements in connection with the appointment.
04—Continue